title: Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil.
authors.affiliation: The Israeli Teratogen Information Service, Israeli Ministry of Health, Jerusalem, Israel.
authors.forename: Orna
authors.initials: O
authors.lastname: Diav-Citrin
authors.forename: Asher
authors.initials: A
authors.lastname: Ornoy
mesh_terms: D000818:Animals; D002231:Carbimazole / Q000009:adverse effects*; D002754:Choanal Atresia / Q000139:chemically induced*; D004476:Ectodermal Dysplasia / Q000139:chemically induced*; D005260:Female; D006042:Goiter / Q000139:chemically induced / Q000196:embryology; D006168:Guinea Pigs; D006801:Humans; D007037:Hypothyroidism; D008713:Methimazole / Q000009:adverse effects*; D051379:Mice; D011247:Pregnancy; D011441:Propylthiouracil / Q000009:adverse effects*; D011817:Rabbits; D051381:Rats; D013723:Teratogens / Q000633:toxicity*; D013961:Thyroid Gland / Q000473:pathology
chemical_list: D013723:Teratogens; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole